Virotherapy - Cancer targeted pharmacology

Virotherapy - Cancer targeted pharmacology

Veure altres versions (1)

Building on their success in vaccination, many groups are now exploring the use of viruses as anticancer agents. In general, viral therapeutics provide the possibility to express anticancer proteins directly at the tumour site, decreasing exposure to normal tissue during delivery and maximising ther...

Descripció completa

Dades bibliogràfiques
Autors principals:	Tedcastle, A, Cawood, R, Di, Y, Fisher, K, Seymour, L
Format:	Journal article
Idioma:	English
Publicat:	2012

Ítems similars

Virotherapy--cancer targeted pharmacology.
per: Tedcastle, A, et al.
Publicat: (2012)

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
per: Green, N, et al.
Publicat: (2012)

Effects of Producer Cell Type on the Properties of Oncolytic Sindbis Virus
per: Kueberuwa, G, et al.
Publicat: (2011)

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
per: Bazan-Peregrino, M, et al.
Publicat: (2008)

Combining virotherapy and angiotherapy for the treatment of breast cancer.
per: Bazan-Peregrino, M, et al.
Publicat: (2013)

Combining virotherapy and angiotherapy for the treatment of breast cancer
per: Bazan-Peregrino, M, et al.
Publicat: (2013)

Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.
per: Morrison, J, et al.
Publicat: (2008)

716 Cell-based virotherapy for targeting cancers
per: Boris Minev, et al.
Publicat: (2020-11-01)

Oncolytic virotherapy: combining first-rate science with an unmet clinical need.
per: Seymour, L
Publicat: (2011)

Factors responsible for inhibition of adenovirus infection by cellular debris and tumour lysate
per: Tedcastle, A, et al.
Publicat: (2011)

Virotherapy in Head and Neck Cancer
per: Zhan Wang
Publicat: (2024-03-01)

Cavitation-enhanced tumour-targeting virotherapy by ultrasound
per: Mo, S
Publicat: (2013)

Oncolytic virotherapy targeting the IL15 pathway
per: So Young Yoo, et al.
Publicat: (2023-12-01)

Oncolytic Virotherapy of Canine and Feline Cancer
per: Ivaylo Gentschev, et al.
Publicat: (2014-05-01)

Oncolytic virotherapy
per: Daniel Cervantes-García;, et al.
Publicat: (2008-01-01)

Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer
per: Khandoker Usran Ferdous, et al.
Publicat: (2024-07-01)

Oncolytic Virotherapy for Cancer: Clinical Experience
per: Shyambabu Chaurasiya, et al.
Publicat: (2021-04-01)

Multidisciplinary oncolytic virotherapy for gastrointestinal cancer
per: Toshiyoshi Fujiwara
Publicat: (2019-07-01)

Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth
per: Tedcastle, A, et al.
Publicat: (2016)

Modeling dynamics of cancer virotherapy with immune response
per: Salma M. Al-Tuwairqi, et al.
Publicat: (2020-08-01)

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
per: D. G. Roy, et al.
Publicat: (2021-05-01)

Editorial: Oncolytic virotherapy
per: Ahmed Majeed Al-Shammari, et al.
Publicat: (2023-11-01)

Advances in oncolytic virotherapy
per: Stephen J. Russell, et al.
Publicat: (2022-04-01)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
per: Thoma, CMM
Publicat: (2011)

Lung cancer and oncolytic virotherapy——enemy's enemy
per: Zhang Li, et al.
Publicat: (2023-01-01)

DNA-damaging cancer cells to improve virotherapy
per: Marc Garcia-Moure, et al.
Publicat: (2022-12-01)

Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.
per: Carlisle, R, et al.
Publicat: (2013)

Oncolytic virotherapy – A novel strategy for cancer therapy
per: Mohanan Geetha Gopisankar, et al.
Publicat: (2018-07-01)

Oncolytic Virotherapy for Hematological Malignancies
per: Swarna Bais, et al.
Publicat: (2012-01-01)

Mathematical modelling of oncolytic virotherapy
per: Shabala, A
Publicat: (2013)

Cellular carriers or free viruses?
per: Seymour, L, et al.
Publicat: (2008)

Recombinant viral vaccines for cancer
per: Cawood, R, et al.
Publicat: (2012)

Recombinant viral vaccines for cancer.
per: Cawood, R, et al.
Publicat: (2012)

Oncolytic virotherapy in head and neck cancer: A hope?
per: Vishnu Priya Veeraraghavan, et al.
Publicat: (2024-03-01)

Oncolytic virotherapy in cancer treatment: challenges and optimization prospects
per: Lingjuan Chen, et al.
Publicat: (2023-12-01)

Oncolytic virotherapy in gastric cancer: Towards precision therapeutics
per: Muhammad Ikrama, et al.
Publicat: (2024-04-01)

Current perspectives of virotherapy as a cancer treatment strategy
per: Lyubov D. Vlasova
Publicat: (2024-12-01)

An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy
per: Muhammad Naveed, et al.
Publicat: (2024-11-01)

The combination therapy of oncolytic virotherapy
per: Yue Wang, et al.
Publicat: (2024-04-01)

Syncytia Formation in Oncolytic Virotherapy
per: Chase Burton, et al.
Publicat: (2019-12-01)